ArticleCancers2020

Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients.

Valeria Merz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.